Meet our Scientific Advisory Board

Arc’s Scientific Advisory Board provides strategic guidance, shares their deep expertise, and plays a key role in guiding and advancing Arc’s mission to accelerate scientific progress and understand the root causes of complex human disease.

SCIENTIFIC ADVISOR

Dr. Carolyn Bertozzi, Ph.D.

Dr. Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology, and an Investigator of the Howard Hughes Medical Institute at Stanford University. Her research focuses on translational chemical biology with particular applications in glycoscience, leading to the development of new diagnostic and therapeutic approaches. In 2022, Dr. Bertozzi was awarded the Nobel Prize in Chemistry for her invention of the field of bioorthogonal chemistry, which allows researchers to study molecules in living things without interfering with natural biological processes. She is also a prolific entrepreneur and the co-founder of Redwood Bioscience, Enable Biosciences, Palleon Pharma, InterVenn Biosciences, OliLux Biosciences, and Lycia Therapeutics. Dr. Bertozzi is also an elected member of the National Academy of Sciences, the National Academy of Medicine and the National Academy of Engineering, as well as a Foreign Member of the Royal Society.

SCIENTIFIC ADVISOR

Dr. Aviv Regev, Ph.D.

Dr. Regev serves as the Executive Vice President and Head of Research and Early Development at Genentech (gRED), a member of the Roche Group, where she leads efforts in drug discovery and drug development. She is also the co-founding co-chair of the international Human Cell Atlas initiative. Dr. Regev pioneered the development of foundational experimental methods and computational algorithms in single-cell genomics, and is a leader in deciphering intra- and intercellular molecular circuits in cells and tissues. Previously, Dr. Regev served as a Professor of Biology at the Massachusetts Institute of Technology, Founding Director of the Klarman Cell Observatory, Co-Director of the Cell Circuits Program at the Broad Institute of MIT and Harvard, and Investigator at the Howard Hughes Medical Institute. Among other honors, Dr. Regev is an elected member of the National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, and an elected foreign member of the UK Royal Society.